3871. Entyvio-H-C-PSUSA-00010186-202005 3872. Emgality-H-C-PSUSA-00010733-202009 3873. Zejula-H-C-PSUSA-00010655-202009 3874. Augagio-H-C-PSUSA-00010135-202009 3875. Rapamune-H-C-PSUSA-00002710-202009 3876. Vectibix-H-C-PSUSA-00002283-202009 3877. Thalidomide Celgene-H-C-PSUSA-00002919-202010 3878. Eviplera-H-C-PSUSA-00009142-202008 3879. Truxima : EPAR-H-C-PSUSA-00002652-202011- Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s) 3880. Imbruvica-H-C-PSUSA-00010301-202011 3881. Noxafil-H-C-610-PSUSA-00002480-202010 3882. Adakveo-H-C-PSUSA-00010888-202011 3883. Eurartesim-H-C-PSUSA-00001069-201910 3884. Ofev-H-C-PSUSA-00010319-202010 3885. MabThera-H-C-PSUSA-00002652-202011 3886. Rydapt-H-C-PSUSA-00010638-202010 3887. Stivarga-H-C-PSUSA-00010133-202009 3888. Tavlesse-H-C-PSUSA-00010819-202010 3889. Rixathon-H-C-PSUSA-00002652-202011 3890. Ruxience-H-C-PSUSA-2652-202011 3891. Prometax-H-C-PSUSA-00002654-202401 3892. Rivastigmine Hexal-H-C-PSUSA-00002654-202401: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3893. Nexium Control-H-C-PSUSA-00001269-202403 - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3894. Tavneos-H-C-PSUSA-00010967/202403 3895. Elucirem-H-C-PSUSA-00000232-202403 3896. Vueway-H-C-PSUSA-00000232-202403 3897. Quviviq-H-C-PSUSA-00010993-202401: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3898. Armisarte-PSUSA-00002330-202402 3899. Pemetrexed Accord-PSUSA-00002330-202402 3900. Rivastigmine 1 A Pharma-H-C-PSUSA-00002654-202401